Previous 10 | Next 10 |
2023-03-08 12:11:38 ET JMP Securities has initiated Lantheus Holdings ( NASDAQ: LNTH ) with a market outperform rating saying the radiopharmaceuticals-focused company has "morphed into a MedTech growth leader with sustainability for years to come." The firm has a $120 pric...
Shares of Lantheus Holdings (NASDAQ: LNTH) were up 21.2% for the week as of Friday afternoon, according to data provided by S&P Global Market Intelligence . The healthcare company released its quarterly results on Thursday, surpassing analysts' forecasts for revenue and e...
Lantheus Holdings, Inc. (LNTH) Q4 2022 Earnings Conference Call February 23, 2023 08:00 AM ET Company Participants Mark Kinarney - Vice President of Investor Relations Mary Anne Heino - President & Chief Executive Officer Paul Blanchfield - Chief Operating Officer ...
Lantheus ( NASDAQ: LNTH ) stock rose ~17% on Thursday after Q4 results beat estimates and the FY23 outlook was placed above expectations. Q4 adjuested EPS grew +448% Y/Y to $1.37, while revenues increased +103% to $263.17M. Both top and bottom line numbers surpassed analysts expec...
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Lantheus Holdings, Inc. 2022 Q4 - Results - Earnings Call Presentation
Lantheus press release ( NASDAQ: LNTH ): Q4 Non-GAAP EPS of $1.37 beats by $0.41 . Revenue of $263.16M (+103.1% Y/Y) beats by $17.83M . 1Q23 Revenue between $280M-$285M vs consensus $256.47M. Adj. EPS between $1.28-$1.32 vs consensus of $1.06 FY23 Revenue between $...
Worldwide revenue of $263.2 million and $935.1 million for the fourth quarter and full year 2022, representing increases of 103.1% and 119.9% over the prior year periods, respectively GAAP net loss of $119.2 million and GAAP net income of $28.1 million for the fourth quarter and full ye...
Lantheus ( NASDAQ: LNTH ) is scheduled to announce Q4 earnings results on Thursday, February 23rd, before market open. The consensus EPS Estimate is $0.96 (compared to $0.25 in year ago quarter) and the consensus Revenue Estimate is $245.33M (+89.3% Y/Y). Over the last 2 years...
BEDFORD, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, tod...
Summary Investors allocating on weakness within new-year rally. Stock wedging up to previous resistance marks, testing key retracement levels. Heavy inflows into LNTH equity into the New Year as well, correlating to the rally off lows. Net-net, reiterate buy, searching for short...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...
BEDFORD, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced its acqu...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...